73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Research reveals pro-phagocytic function and structural basis of GPR84 signaling

Research reveals pro-phagocytic function and structural basis of GPR84 signaling

by University of Science and Technology of ChinaGPR84-Gi signaling facilitates cancer cell phagocytosis. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41201-0A recent study,

Research reveals pro-phagocytic function and structural basis of GPR84 signaling

by University of Science and Technology of ChinaGPR84-Gi signaling facilitates cancer cell phagocytosis. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41201-0A recent study,
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi
How Can You Increase Your Red Blood Cells?

How Can You Increase Your Red Blood Cells?

How Can You Increase Your Red Blood Cells?Maintaining optimal levels is important for your healthByHeidi Moawad, MDUpdated on April 17, 2023Medically reviewed byJeffrey S. Land

How Can You Increase Your Red Blood Cells?

How Can You Increase Your Red Blood Cells?Maintaining optimal levels is important for your healthByHeidi Moawad, MDUpdated on April 17, 2023Medically reviewed byJeffrey S. Land
A case for routine evaluation of HER2 expression in ductal carcinoma in situ

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde
Study finds new feature indicative of gastrointestinal tumor recurrence

Study finds new feature indicative of gastrointestinal tumor recurrence

by CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurre

Study finds new feature indicative of gastrointestinal tumor recurrence

by CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurre
Scientists to improve cancer treatment effectiveness

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N
BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit
Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

by University of Miami Leonard M. Miller School of Medicine“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especi

Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

by University of Miami Leonard M. Miller School of Medicine“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especi
For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal
Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

bySt. Jude Children's Research HospitalTwo leucine zipper motifs endow ZipRs with constitutive signal transduction.a, Schematic of IL-2 receptor-based Zip2Rs with phosphorylated (p) JA

Modular chimeric cytokine receptors improve CAR T-cell therapy for solid tumors

bySt. Jude Children's Research HospitalTwo leucine zipper motifs endow ZipRs with constitutive signal transduction.a, Schematic of IL-2 receptor-based Zip2Rs with phosphorylated (p) JA
Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with